Login / Signup

Genome-wide CRISPR/Cas9 library screening identified OGDH as a regulator of disease progress and resistance to decitabine in myelodysplastic neoplasm by reprogramming glutamine metabolism.

Xiaoyan XuJiaqian QiHong WangZiyan ZhangTingting PanXueqian LiJingyi YangHaohao HanMengting GuoMeng ZhouChengsen CaiYaqiong TangQixiu HouSuning ChenDepei WuYue Han
Published in: Leukemia (2024)
Keyphrases
  • crispr cas
  • acute myeloid leukemia
  • genome wide
  • genome editing
  • dna methylation
  • bone marrow
  • low grade
  • transcription factor
  • gene expression